Stockholm, Sweden, 27 June, 2019 – Coala Life, a Swedish digital heart monitoring system that helps predict and promote treatment of heart disease, has won the backing of the Stockholm-based international impact-led investment company Blue, which has placed an additional SEK10 million investment in the company following an earlier round of SEK93 million announced in April this year.
The fresh capital intake from Blue will enable Coala Life to further accelerate its current commercialization activities around its digital heart monitor and spur its launch into the United States.
A pioneer in digital heart diagnosis and individual focused medical innovations, Coala Life secured 510(k) approval from the U.S. FDA, which opens the door to the huge American marketplace for company’s unique heart monitor system that helps predict and prevent heart disease,” said Anders Jacobson, co-founder and CEO of Blue.
Philip Siberg, Coala Life President, said: “We are now ready to accelerate our growth plans outside Sweden. Together with Blue we will give people the opportunity to monitor their hearts to help predict and prevent heart disease.”
The Coala Life medical system allows individuals to record and analyse their heart beat and ECG in just sixty seconds using smart, cloud-based algorithms that analyze and monitor Atrial Fibrillation (based on P-wave detection and RR variability) and eight other arrhythmia's as well as detect murmurs. Ideal for smart remote assessments and telemedicine, the results are presented in the Coala App and the Coala Care cloud based system within seconds.
By putting people in control of their own heart health, the Coala Life system typifies the game-changing sustainable tech innovations for people’s health that Blue focuses its investment strategies on and wants to make happen.
Coala Life is a Swedish digital health venture focused on cardiac diagnostics and digital health. The company has developed a portfolio of patented medical products and services for user-centered digital remote monitoring and screening of the heart based on advanced and smart algorithms. Coala's solutions enable analysis, remote monitoring, more effective cardiac assessments and integrated care services, all in real time. Coala was named one of five global Cool Vendors within the Health and Wellness market by Gartner Group in 2018 and recognized as of the 100 Global Leaders in Digital Health by the Journal of mHealth. For more information see www.coalalife.com
For more information, please contact David Noble, Blue PR & Communications Director, at firstname.lastname@example.org or +44 7785302694
Headquartered in Stockholm, Sweden, Blue is an investment company that serves as a catalyst for innovations that can solve some of the major challenges facing our planet and all living on it. Blue’s mission is to find, engage with, invest in and support entrepreneurs, innovators and businesses driven by the desire to deliver tangible, sustainable solutions that can benefit human wellbeing and planetary health.www.blueab.se